Vaxart Inc (VXRT)
0.89
-0.10
(-10.41%)
USD |
NASDAQ |
May 23, 16:00
0.89
0.00 (0.00%)
After-Hours: 20:00
Vaxart Revenue (Annual): 7.379M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.379M |
| December 31, 2022 | 0.107M |
| December 31, 2021 | 0.892M |
| December 31, 2020 | 4.046M |
| December 31, 2019 | 9.862M |
| December 31, 2018 | 4.159M |
| June 30, 2017 | 8.90M |
| June 30, 2016 | 9.30M |
| June 30, 2015 | 24.60M |
| June 30, 2014 | 68.70M |
| June 30, 2013 | 33.60M |
| December 31, 2011 | 14.84M |
| December 31, 2010 | 35.00M |
| December 31, 2009 | 10.49M |
| December 31, 2008 | |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | 142.18M |
| Date | Value |
|---|---|
| December 31, 2003 | 176.57M |
| December 31, 2002 | 195.97M |
| December 31, 2001 | 234.83M |
| December 31, 2000 | 228.78M |
| December 31, 1999 | 233.60M |
| December 31, 1998 | 243.10M |
| December 31, 1997 | 228.70M |
| December 31, 1996 | 239.90M |
| December 31, 1995 | 202.00M |
| December 31, 1994 | 164.70M |
| December 31, 1993 | 101.60M |
| December 31, 1992 | 82.40M |
| December 31, 1991 | 68.20M |
| December 31, 1990 | 72.80M |
| December 31, 1989 | 59.20M |
| December 31, 1988 | 47.30M |
| December 31, 1987 | 43.10M |
| December 31, 1986 | 43.70M |
| December 31, 1985 | 34.20M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.107M
Minimum
2022
9.862M
Maximum
2019
4.457M
Average
4.046M
Median
2020
Revenue (Annual) Benchmarks
| Novavax Inc | 556.38M |
| Allogene Therapeutics Inc | 0.095M |
| Inovio Pharmaceuticals Inc | 0.832M |
| Stereotaxis Inc | 26.77M |
| Capricor Therapeutics Inc | 25.18M |